SummaryRAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras stability is regulated remains largely unknown. Here, we report a regulatory loop involving the E3 ligase Nedd4-1, Ras, and PTEN. We found that Ras signaling stimulates the expression of Nedd4-1, which in turn acts as an E3 ubiquitin ligase that regulates Ras levels. Importantly, Ras activation, either by oncogenic mutations or by epidermal growth factor (EGF) signaling, prevents Nedd4-1-mediated Ras ubiquitination. This leads to Ras-induced Nedd4-1 overexpression, and subsequent degradation of the tumor suppressor PTEN in both human cancer samples and cancer cells. Our study thus unravels the molecular mechanisms underlying the interplay of R...
The HECT domain-containing ubiquitin E3 ligase NEDD4 is widely expressed in mammalian tissues and pl...
We previously identified 28 cofactors through which a RAS oncoprotein directs transcriptional silenc...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
RAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras stabilit...
SummaryRAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras s...
The genetic alterations in cancer cells are tightly linked to signaling pathway dysregulation. Ras i...
The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or delet...
SummaryThe tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated o...
The apoptosis-promoting protein Par-4 has been shown to be down-regulated in Ras-transformed NIH 3T3...
Neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) is an E3 ubiquitin lig...
Background: Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. It is hig...
Proper regulation of cell proliferation, cell apoptosis, and cell death are vital for the developmen...
Activated Ras but not Raf can transform RIE-1 and other epithelial cells, indicating the critical im...
Abnormally activated RAS proteins are the main oncogenic driver that governs the functioning of majo...
Activation of the RAS oncogenic pathway, frequently ensuing from mutations in RAS genes, is a common...
The HECT domain-containing ubiquitin E3 ligase NEDD4 is widely expressed in mammalian tissues and pl...
We previously identified 28 cofactors through which a RAS oncoprotein directs transcriptional silenc...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
RAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras stabilit...
SummaryRAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras s...
The genetic alterations in cancer cells are tightly linked to signaling pathway dysregulation. Ras i...
The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or delet...
SummaryThe tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated o...
The apoptosis-promoting protein Par-4 has been shown to be down-regulated in Ras-transformed NIH 3T3...
Neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) is an E3 ubiquitin lig...
Background: Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. It is hig...
Proper regulation of cell proliferation, cell apoptosis, and cell death are vital for the developmen...
Activated Ras but not Raf can transform RIE-1 and other epithelial cells, indicating the critical im...
Abnormally activated RAS proteins are the main oncogenic driver that governs the functioning of majo...
Activation of the RAS oncogenic pathway, frequently ensuing from mutations in RAS genes, is a common...
The HECT domain-containing ubiquitin E3 ligase NEDD4 is widely expressed in mammalian tissues and pl...
We previously identified 28 cofactors through which a RAS oncoprotein directs transcriptional silenc...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...